| Literature DB >> 33584342 |
Ricardo Wesley Alberca1, Júlia Cataldo Lima1, Emily Araujo de Oliveira1,2, Sarah Cristina Gozzi-Silva1,2, Yasmim Álefe Leuzzi Ramos1, Milena Mary de Souza Andrade1, Danielle Rosa Beserra1, Luana de Mendonça Oliveira1,2, Anna Cláudia Calvielli Castelo Branco1,2, Anna Julia Pietrobon1,2, Nátalli Zanete Pereira1, Franciane Mouradian Emidio Teixeira1,2, Iara Grigoletto Fernandes1, Alberto José da Silva Duarte1, Gil Benard1, Maria Notomi Sato1.
Abstract
The severe respiratory and systemic disease named coronavirus disease-2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, the COVID-19 pandemic presents a huge social and health challenge worldwide. Many different risk factors are associated with disease severity, such as systemic arterial hypertension, diabetes mellitus, obesity, older age, and other co-infections. Other respiratory diseases such as chronic obstructive pulmonary disease (COPD) and smoking are common comorbidities worldwide. Previous investigations have identified among COVID-19 patients smokers and COPD patients, but recent investigations have questioned the higher risk among these populations. Nevertheless, previous reports failed to isolate smokers and COPD patients without other comorbidities. We performed a longitudinal evaluation of the disease course of smokers, former smokers, and COPD patients with COVID-19 without other comorbidities, from hospitalization to hospital discharge. Although no difference between groups was observed during hospital admission, smokers and COPD patients presented an increase in COVID-19-associated inflammatory markers during the disease course in comparison to non-smokers and former smokers. Our results demonstrated that smoking and COPD are risk factors for severe COVID-19 with possible implications for the ongoing pandemic.Entities:
Keywords: COVID-19; SARS-CoV-2; chronic obstructive pulmonary disease; infection; smoking
Year: 2021 PMID: 33584342 PMCID: PMC7873569 DOI: 10.3389/fphys.2020.637627
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566